The United States Patent and Trademark Office has issued US Patent No. 10682414, titled, "Intranasal epinephrine formulations and methods for the treatment of disease," to ARS Pharmaceuticals, the company said. The patent covers the use of low dose (0.1 to 2.4 mg) intranasal epinephrine for for the treatment of anaphylaxis. The patent covers any low-dose … [Read more...] about ARS Pharmaceuticals gets second US patent for its epinephrine nasal spray
News
Teva launches ProAir Digihaler in the US
Teva has announced the US launch of the ProAir Digihaler albuterol DPI for the treatment of bronchospasm. The list price for the inhaler will be $146.67. ProAir Digihaler, which includes built-in sensors connected to a mobile app via Bluetooth, was approved by the FDA in December 2018. The company said that it also has plans to launch the AirDuo Digihaler … [Read more...] about Teva launches ProAir Digihaler in the US
Nephron Pharmaceuticals announces expansion plans
Inhalation solutions and suspensions manufacturer Nephron Pharmaceuticals has announced plans for a $215 million expansion at its South Carolina, USA facilities, including office, warehouse and vaccine production space. In addition to manufacturing its own products, Nephron also offers contract manufacturing services for sterile pharmaceutical products. The expansion … [Read more...] about Nephron Pharmaceuticals announces expansion plans
Optinose partners with Kaleo for promotion of Xhance intranasal fluticasone
Optinose announced that it has signed an agreement with Kaleo for co-promotion of Optinose's Xhance fluticasone propionate nasal spray for the treatment of nasal polyps. Xhance was approved by the FDA for that indication in September 2017. The agreement calls for Kaleo to promote the nasal spray to a group of almost 6,000 healthcare providers in the US. Optinose … [Read more...] about Optinose partners with Kaleo for promotion of Xhance intranasal fluticasone
CEBINA says azelastine nasal spray has potential for COVID-19
Vienna-based biotech incubator CEBINA (Central European Biotech Incubator and Accelerator) said that in vitro testing has shown that azelastine has anti-SARS-CoV-2 activity, and the company is discussing possible development and production of an azelastine nasal spray for the treatment of COVID-19 with Sigmapharm. CEBINA added that it has also filed a patent … [Read more...] about CEBINA says azelastine nasal spray has potential for COVID-19
Altimmune partners with DynPort Vaccine on intranasal COVID-19 vaccine
Altimmune said that it has signed an agreement with DynPort Vaccine Company regarding Altimmune's AdCovid intranasal vaccine candidate for COVID-19. The company announced in March 2020 that it had partnered with the University of Alabama Birmingham to develop AdCOVID. According to Altimmune, "The partnership with DVC significantly expands Altimmune’s capabilities … [Read more...] about Altimmune partners with DynPort Vaccine on intranasal COVID-19 vaccine
BNC Korea acquires rights to Iconovo’s generic versions of Ultibro and Seebri for Asia, CIS countries
Iconovo announced that BNC Korea has acquired rights to manufacture and market generic versions of Ultibro indacaterol/glycopyrronium and Seebri glycopyrronium DPIs based on Iconovo formulations and the company's ICOcap device. The deal covers a territory that includes Korea, Japan, China, Taiwan, Turkey, and Russia, as well as additional CIS and southeast Asian … [Read more...] about BNC Korea acquires rights to Iconovo’s generic versions of Ultibro and Seebri for Asia, CIS countries
Lonza announces new Center of Excellence for DPI particle engineering and formulation
Lonza Pharma & Biotech has established a new Center of Excellence for DPI development at its location in Bend, OR, USA, the company said. The site originally belonged to spray drying specialist Bend Research, which was acquired by Capsugel in 2013; Capsugel was subsequently acquired by Lonza in 2017. According to Lonza, "the core service offer is … [Read more...] about Lonza announces new Center of Excellence for DPI particle engineering and formulation
Koura announces donation of inhalers to Maharashtra government for COVID-19, innovation award for Zephex 152a
Medical propellant maker Koura announced that it has donated 10,000 MDIs to the government of the Indian state of Maharashtra to help meet the demand for inhalers during the COVID-19 pandemic. Specifically, the company said that the inhalers are designated for the Haffkine Institute in Mumbai. Koura also announced that it has won the Chemicals Northwest 2020 … [Read more...] about Koura announces donation of inhalers to Maharashtra government for COVID-19, innovation award for Zephex 152a
iPharma Labs announces addition of GMP testing services, new board members and management hires
Inhalation contract R&D company iPharma Labs has announced the introduction of new GMP testing services for testing and development of OINDPs, including inhaled drugs for the treatment of COVID-19. The company also announced the addition of two board members and two management hires with extensive experience in the inhaled drug delivery industry. The iPharma … [Read more...] about iPharma Labs announces addition of GMP testing services, new board members and management hires